🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Schuler

Boehringer Ingelheim (Germany)

ORCID: 0009-0008-4933-4972
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells.

0 citations

Marta Puig Gámez, Eva M. Garrido‐Martín, Łukasz M. Boryń, Praveen Baskaran, Heinrich J. Huber +4 more

0 citations

Corina de Jong, Danijel Jelusic, Michael Wittmann, Michael Schuler, Konrad Schultz +2 more